Amexdrug Corp AXRX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.15 / $0.16
- Market Cap
- $355,125.08
- Volume/Avg
- 1,280 / 1,280
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Amexdrug Corp is a pharmaceutical and cosmeceutical company. Along with its subsidiaries, the company engaged in the research and development, manufacturing and distribution of pharmaceutical drugs, cosmetics and distribution of prescription and over-the-counter drugs, private manufacturing and labeling, and a quality control laboratory. It has operations in two segments, Distribution; and Health and Beauty Products. The distribution segment consists of the wholesale pharmaceutical distribution and resale of brand and generic pharmaceutical products, over-the-counter drugs and non-drug products, and health and beauty products. Health and Beauty Products consist of the manufacture and distribution of primary health and beauty products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 13
- Website
- https://www.amexdrug.com
Valuation
|
Metric
|
AXRX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
AXRX
|
|---|---|
Quick Ratio | 0.67 |
Current Ratio | 1.35 |
Interest Coverage | 6.99 |
Quick Ratio
No chart available
Profitability
|
Metric
|
AXRX
|
|---|---|
Return on Assets (Normalized) | 7.97% |
Return on Equity (Normalized) | 30.57% |
Return on Invested Capital (Normalized) | 13.70% |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Hwgjyfxj | Sfpn | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Bypgjxsmc | Zrlqp | $68.1 Bil | |
HLN
| Haleon PLC ADR | Bfxspyd | Zckc | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Nkkldbb | Ppsq | $14.3 Bil | |
VTRS
| Viatris Inc | Gcgjfqbqm | Qfkcl | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Nwgtwfxc | Yyvb | $12.0 Bil | |
CTLT
| Catalent Inc | Xdsxcdhb | Tzhqr | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Cdvvstd | Dqxy | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Vpntblkd | Jfs | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Pldwwjps | Bwypcm | $3.4 Bil |